Using these proxy measures in a prospective study of schizophrenia patients, Tenback and colleagues showed associations between incidence of TD on the one hand and occurrence of EPS [9], prolactin-related adverse effects [4] and worsening of psychotic symptoms on the other [6], suggesting general DA dysregulation across the different DA tracts in schizophrenia. Here, PRL is linked to schizophrenia.